Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Surgical ablation for treating atrial fibrillation during heart surgery

Official title: Surgical Ablation of AF Efficacy Trial

Run by Population Health Research Institute · NCT05434819 · Data updated 2026-11-12

This study is testing if a surgical procedure to treat atrial fibrillation during heart surgery can help patients have better heart health and lower their chances of stroke and heart failure compared to standard care.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorPopulation Health Research Institute
Academic / other
Locations1 site (Hamilton, Ontario)
StatusRecruiting
StartedJune 1, 2023
Main results expectedSeptember 30, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 5, 2026
Trial IDNCT05434819 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have a documented history of paroxysmal or persistent atrial fibrillation and are scheduled for clinically indicated cardiac surgery.

Probably not a fit

Patients with dominant atrial flutter, significant left atrial enlargement, or those undergoing specific cardiac procedures unrelated to AF may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The SAFE trial is an international multicenter randomized controlled trial investigating the efficacy of surgical ablation for atrial fibrillation (AF) in patients undergoing cardiac surgery. It aims to determine whether surgical ablation can improve cardiovascular outcomes by maintaining sinus rhythm in patients with paroxysmal or persistent AF. The trial will compare outcomes between patients receiving surgical ablation and those receiving standard care, with a focus on the potential benefits of this intervention in reducing the risk of stroke and heart failure. This landmark trial seeks to provide robust evidence on the impact of surgical AF ablation in the context of cardiac surgery.

Why it matters

Potential benefit: If successful, this trial could significantly improve the management of atrial fibrillation in patients undergoing cardiac surgery, potentially reducing the risk of stroke and heart failure.

How similar studies have gone: Previous studies have shown promising results for catheter-based AF ablation, suggesting that surgical ablation may also yield beneficial outcomes, although this specific approach is less commonly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years;
* Undergoing a clinically indicated cardiac surgical procedure: CABG, AVR, ascending aorta replacement, or combinations thereof;
* Documented history of paroxysmal or persistent AF
* Provide informed consent

Exclusion Criteria:

* Dominant atrial arrhythmia is atrial flutter;
* Documented left atrial diameter ≥ 6 cm;
* Previous cardiac surgery requiring opening of the pericardium;
* Patients undergoing any of the following procedures:

  1. Heart transplant
  2. Complex congenital heart surgery
  3. Sole indication for surgery is ventricular assist device insertion
  4. Mitral valve repair or replacement
  5. Tricuspid valve repair or replacement
* Patient resides in a long-term care facility

Where it's running

  • Hamilton General Hospital
    Hamilton, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.